Advertisement

Virchows Archiv A

, Volume 404, Issue 1, pp 87–97 | Cite as

Renal immunopathology in renal cell carcinoma

  • H. Beaufils
  • R. Patte
  • Ph. Aubert
  • M. Camey
  • R. Kuss
  • M. Barbagelatta
  • G. Chomette
Article

Summary

Signs of glomerulopathy, especially a nephrotic syndrome can occur in cancer patients, but the exact frequency of glomerular lesions is not well known in these patients. To define this frequency in a given type of malignancy we have studied the nephrectomy kidneys in 40 patients with renal cell carcinoma. Proteinuria, which was present in 7 cases, ranged from 0.15 to 1.5 g per 24 h. Reduction of the creatinine clearance greater than 50% was observed in 5 patients. Circulating immune complexes were detected in 11 of the 15 patients studied. Carcinoembryonic antigens were noted in 2 of 9 patients investigated. Research of alpha 1 foetoprotein carried out in 12 patients was always negative. HBs antigen or Hbs antibodies were detected in 6 of 29 patients studied. Light microscopic examination of the normal uninvolved kidney tissue showed obvious glomerular lesions (mesangial hypertrophy with or without deposits, with or without cell proliferation) in 7 patients (17.5%). Amyloid deposits were never observed. Immunofluorescence study revealed mesangial deposits in 35% of patients versus 5.4% of control subjects (P < 0.0001). These deposits included C3 and/or IgM in 13 cases, IgA and C3 in one case. No fixation was observed, neither on tubules of normal tissue nor on carcinoma lesions. This report demonstrates that glomerular deposits are usually found in approximately one third of patients with renal cell carcinoma and that these deposits are located in the mesangial areas and not in the subepithelial space as it is often observed when glomerulonephritis is expressed by clinical symptoms.

Key words

Glomerular deposits Immunofluorescence microscopy Renal cell carcinoma 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ask-Upmark E (1940) On amyloidosis induced by tumors of the kidney. Acta Med Scand 104:512–525Google Scholar
  2. Bennington JL (1973) Cancer of the kidney. Etiology, epidemiology and pathology. Cancer 32:1017–1029Google Scholar
  3. Beregi E, Hamvas A, Renyi-Vamos F (1974) Immunohistological studies in chronic pyelonephritis. Clin Nephrol 2:113–115Google Scholar
  4. Berger L, Sinkoff MW (1957) Systemic manifestations of hypernephroma. A review of 273 cases. Am J Med 22:791–796Google Scholar
  5. Berthoux FC, Zech PY, Blanc-Brunat N, Colon S, Ducret F, Traeger J (1976) Association syndrome néphrotique - maladie de Hodgkin: rôle du virus Epstein-Barr. Nouv Presse Med 5:255–258Google Scholar
  6. Carter RL (1968) The pathology of renal cancer. J Am Med Ass 204:221–222Google Scholar
  7. Chisholm GD, Roy RR (1971) The systemic effects of malignant renal tumours. Br J Urol 43:687–700Google Scholar
  8. Chu TM, Shukla SK, Mittleman AO, Murphy GP (1974) Plasma carcinoembryonic antigen in renal cell carcinoma patients. J Urol 111:742–744Google Scholar
  9. Costanza ME, Pinn V, Schwartz RS, Nathanson L (1973) Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome. N Engl J Med 289:520–522Google Scholar
  10. Couser WG, Wagonfeld JB, Spargo BH, Lewis EJ (1974) Glomerular deposition of tumor antigen in membranous nephropathy associated with colonic carcinoma. Am J Med 57:962–970Google Scholar
  11. Couser WC, Colvin RB (1980) Renal mass and the nephrotic syndrome in a 71 year old man. New Eng J Med 303:985–995Google Scholar
  12. Cronin RE, Kaehny WD, Miller PD, Stables DP, Gabow PA, Ostroy PR, Schrier RW (1976) Renal cell carcinoma: unusual systemic manifestations. Medicine 55:291–311Google Scholar
  13. Crouzat-Reynes G, Perigois F, Lecureuil M (1982) Detection de l'antigène HBs. Analyse d'une confrontation interlaboratoires concernant les différentes méthodes de détection utilisées dans les centres de transfusion sanguine de la région centre. Rev Franç Trans Immun 25:49–55Google Scholar
  14. Cukier J, Amiel JL, Bronstein M, Droz JP (1979) Cancer du rein chez l'adulte. Résultat du traitement actuel. 120 cas. Nouv Presse Med 8:319–321Google Scholar
  15. Davis S, Marquet E, Rambotti P, Sobel HJ (1980) Electron microscopic and immunohistochemical analysis of glomerular deposits in patients with bronchogenic carcinoma; Ultrastr Pathol 1:527–531Google Scholar
  16. Denis J, Mignon F, Ramée MP, Morel-Maroger L, Richet G (1978) Glomerulonéphrites extramembraneuses associées aux tumeurs viscérales. Etude clinique et histologique, à propos de 10 cas et revue de la littérature. Nouv Presse Med 7:991–996Google Scholar
  17. Dupond JL, Apffel F, Colas JM, Leconte des Floris R (1980) Syndrome néphrotique é lésions glomérulaires minimes révélateur d'un cancer du rein. Nouv Presse Med 9:884–885Google Scholar
  18. Eagen JW, Lewis EJ (1977) Glomerulopathies of neoplasia. Kidney Int 11:297–306Google Scholar
  19. Gluckman JC, Jacob N, Beaufils H, Baumelou A, Salah H, German A, Legrain M (1978) Clinical significance of circulating immune complexes detection in chronic glomerulonephritis. Nephron 22:138–145Google Scholar
  20. Grangeot L, Pillot J (1975) Mise en évidence d'immuns complexes circulants chez l'homme: précipitation des immuns complexes par le polyéthylène glycol et leur caractérisation par le C1q lié aux immunoglobulines. CR Acad Sc Paris 280:1201–1203Google Scholar
  21. Grossman SH, Croker BP (1978) Additional studies of membranous glomerulonephritis, malignant tumors and carcinoembryonic antigen. Kidney Int 14:711Google Scholar
  22. Helin H, Pasternack A, Hakala T, Penttinen K, Wager O (1980) Glomerular electrondense deposits and circulating immune complexes in patients with malignant tumours. Clin Nephrol 14:23–30Google Scholar
  23. Higgins MR, Randall RE, Still WJS (1974) Nephrotic syndrome with oat-cell carcinoma. Br Med J 3:450–451Google Scholar
  24. Holm S, Wahlin A, Wahlqvist L, Wedren H (1982) Plasma proteins and anti-kidney antibodies in renal carcinoma. Scand J Urol Nephrol 16:163–166Google Scholar
  25. Hopper J Jr, Biava CB, Naughton JL (1976) Glomerular extracapillary proliferation (crescentic glomerulonephritis) associated with non renal malignancies. Kidney Int 10:544Google Scholar
  26. Hyman LR, Burkholder PM, Joo PA, Segar WE (1973) A clinico-pathologic analysis with light, immunofluorescence, and electron microscopy of the renal lesions. J Pediatr 82:207–217Google Scholar
  27. Kerpen HO, Bhat JG, Feiner HD, Baldwin DS (1978) Membranous nephropathy associated with renal cell-carcinoma. Evidence against a role of renal tubular antibodies in pathogenesis. Am J Med 64:863–867Google Scholar
  28. Lee JC, Yamaucki H, Hopper J (1966) The association of cancer and the nephrotic patients. Ann Intern Med 64:41–51Google Scholar
  29. Lewis MG, Loughridge LW, Phillips TM (1971) Immunological studies in nephrotic syndrome associated with extra-renal malignant disease. Lancet 2:134–135Google Scholar
  30. Mc Canse LRA, Moree JD, Markel L, Mebust WK (1975) Renal cell carcinoma presenting with nephrotic syndrome: a case report and review of the literature. J Urol 114:938–939Google Scholar
  31. Mignon F, Beaufils H, Morel-Maroger L, Clauvel JP, Valla D, Aubert P (1982) Glomérulopathies au cours des affections malignes in Séminaires d'Uro-Néphrologie Pitié-Salpétrière, Küss R, Legrain M (eds) Masson, Paris, pp 171–193Google Scholar
  32. Oldstone MBA, Theofilopoulos AN, Gunven P, Klein G (1974) Immune complexes associatedwith neoplasis. Presence of Epstein-Barr virus antigen-antibody complexes in Burkitt's lymphoma. Intervirology 4:292–302Google Scholar
  33. Olson JL, Philips TM, Lewis MG, Solez K (1979) Malignant melanoma with renal dense deposits containing tumor antigens. Clin Nephrol 12:74–82Google Scholar
  34. Ozawa T, Pluss R, Lacher J, Boedecker E, Guggenheim S, Hammond W, Mc Intosch R (1975) Endogenous immune complex nephropathy associated with malignancy. I. Studies on the nature and immunopathogenic significance of glomerular bound antigen and anti-body isolation and characterization of tumor specific antigen and antibody and circulating immune complexes. Q J Med 44:523–541Google Scholar
  35. Ozawa T (1978) Isolation and characterization of glomerular bound immunoglobulins in lungcarcinoma. Kidney Int 14:716Google Scholar
  36. Pascal RR, Iannoccone PM, Rollwagen FM, Harding TA, Bennet SJ (1976) Electron microscopy and immunofluorescence of glomerular immune complex deposits in cancer deposits. Cancer Res 36:43–47Google Scholar
  37. Pascal RR, Slovin SF (1980) Tumor directed antibody and carcino-embryonic antigen in the glomeruli of a patient with gastric carcinoma. Hum Pathol 11:679–682Google Scholar
  38. Penman HG, Thomson KJ (1972) Amyloidosis and renal adenocarcinoma: a post-mortem study. J Pathol 107:45–47Google Scholar
  39. Pras M, Franklin EG, Shibolet S, Frangione B (1982) Amyloidosis associated with renal cell carcinoma of the AA type. Am J Med 73:426–428Google Scholar
  40. Robson CJ, Churchill BM, Anderson W (1969) The results of radical nephrectomy for renal cell carcinoma. J Urol 101:297–301Google Scholar
  41. Rossen RD, Reisberg MA, Hersh EM, Gutterman JU (1977) The C1q binding test for soluble immune complexes. Clinical correlations obtained in patients with cancer. J Natl Cancer Inst 58:1205–1215Google Scholar
  42. Sutherland JC, Markham RV, Mardiney MR (1974) Subclinical immune complexes in the glomeruli of kidneys post-mortem. Am J Med 57:536–541Google Scholar
  43. Tannenbaum M (1971) Ultrastructural pathology of human renal cell tumors. Pathol Annu 6:249–261Google Scholar
  44. Tard PH, Roche-Sicot J, Tereau Y (1980) Confrontation clinico-anatomique de la Pitié-Salpétrière. Ann Med Int 131:57–63Google Scholar
  45. Teshima H, Wanebo H, Pinsky C, Day NK (1977) Circulating immune complexes detected by125I-C1q deviation test in sera of cancer patients. J Clin Invest 59:1134–1142Google Scholar
  46. Wakashin M, Wakashin Y, Iesato K, Mori Y, Tsuchida H, Shigematsu H, Okuda K (1980) Association of gastric cancer and nephrotic syndrome. An immunologic study in three patients. Gastroenterology 78:749–756Google Scholar
  47. Weksler ME, Carey T, Day N, Susin N, Sherman R, Becker C (1974) Nephrotic syndrome in malignant melanoma: demonstration of melanoma antigen-antibody complexes in kidney. Kidney Int 6:112Google Scholar

Copyright information

© Springer-Verlag 1984

Authors and Affiliations

  • H. Beaufils
    • 1
  • R. Patte
    • 1
  • Ph. Aubert
    • 2
  • M. Camey
    • 2
  • R. Kuss
    • 1
  • M. Barbagelatta
    • 2
  • G. Chomette
    • 1
  1. 1.INSERM U.27, Department of PathologyGroupe Hospitalier Pitié-SalpétrièreParis Cedex 13France
  2. 2.C.M.C. FOCHSuresnesFrance

Personalised recommendations